Sientra, Inc. Stock Price, News & Analysis

Sientra, Inc. (NASDAQ: SIEN) reported Q2 2020 financial results, revealing total net sales of $12.4 million, a 39% decrease from $20.5 million in Q2 2019. Breast Products segment sales dropped 17% to $9.3 million, while miraDry sales plummeted 66% to $3.1 million. Gross profit was $6.9 million (55.4% of sales), down from $12.7 million (61.9%) year-over-year. Despite a net loss of $34.3 million ($0.68 per share), adjusted EBITDA improved with a loss of $9.2 million compared to $20.4 million the previous year. Management forecasts operating expenses of $105-$110 million for 2020.

Sientra, a medical aesthetics company, will participate in the virtual Canaccord 40th Annual Growth Conference. The presentation is scheduled for August 13, 2020, at 4:00 p.m. EDT. An audio webcast will be accessible on Sientra's investor relations website, with a replay available for 90 days. Based in Santa Barbara, California, Sientra offers innovative medical aesthetics products, including advanced breast implants and the miraDry system for permanent underarm sweat reduction.

Sientra, Inc. (NASDAQ: SIEN) will release its Q2 2020 financial results on August 10, 2020, after market close. A conference call to discuss the results is scheduled for the same day at 4:30 p.m. ET, with dial-in access available for both domestic and international callers. The call will also be webcast live on the company’s Investor Relations website and archived for future access. Sientra continues to enhance its portfolio in the medical aesthetics market, focused on improving patients’ self-esteem and body image.

Sientra, Inc. (NASDAQ: SIEN) will participate in a virtual panel discussion titled Beauty after the Beast – Aesthetics during COVID-19 on July 16, 2020, at 11:00 a.m. ET, hosted by Maxim Group and M-Vest. The discussion aims to address the impact of the pandemic on medical aesthetics. Sientra specializes in medical aesthetics, offering innovative products like OPUS® breast implants and the miraDry® system. The webinar is part of Maxim’s series focused on re-engaging medical practices during COVID-19. Interested attendees can RSVP via a provided link.

Sientra, a medical aesthetics company, will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference on June 9, 2020, at 2:00 p.m. CDT. The audio webcast will be accessible via the investor relations section of Sientra's website. Sientra is known for its innovative products like the OPUS breast implants and miraDry system, aimed at enhancing patients' body image and self-esteem. A replay of the chat will be available for 90 days following the event.

Sientra, Inc. (NASDAQ: SIEN) announced it will release its financial results for Q1 2020 after market close on May 11, 2020. A conference call is scheduled for the same day at 5:00 p.m. ET to discuss these results. Domestic callers can dial 844-464-3933, while international participants can reach 765-507-2612 using conference ID 3594402. The call will be webcast live on Sientra's Investor Relations website and archived for later access. Sientra focuses on medical aesthetics, offering advanced breast products and the miraDry system for sweat and odor treatment.